C. Pedersen

B. Feldt-Rasmussen, C. Larsen, G. Pedersen, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Discontinuation and Dose Adjustment of Tenofovir in HIV Patients with Impaired Renal Function

G. Kronborg, C. Pedersen, N. Obel, 2013 .

Renal function and incidence of chronic kidney disease in HIV patients: A Danish cohort study

O. Kirk, B. Feldt-Rasmussen, G. Kronborg, 2012, Scandinavian journal of infectious diseases.

Advanced chronic kidney disease, end‐stage renal disease and renal death among HIV‐positive individuals in Europe

A. Mocroft, O. Kirk, J. Lundgren, 2013, HIV medicine.

Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study

B. Feldt-Rasmussen, C. Larsen, G. Kronborg, 2015, Clinical epidemiology.

Prescription of antimicrobials in primary health care as a marker to identify people living with undiagnosed HIV infection, Denmark, 1998 to 2016

J. Søndergaard, C. Pedersen, N. Obel, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Changing Demographics in an HIV-infected Population: Results from an Observational Cohort Study in Western Denmark

S. Jensen-Fangel, C. Larsen, C. Pedersen, 2001, Scandinavian journal of infectious diseases.

Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study

A. Pottegård, C. Larsen, G. Kronborg, 2017, Infectious diseases.

Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality – Results from a 10-Year Prospective Cohort Study

C. Pedersen, Hanne Madsen, I. Titlestad, 2013, PloS one.

Association Between Educational Level and Risk of Cancer in HIV-infected Individuals and the Background Population: Population-based Cohort Study 1995-2011.

S. Dalton, C. Larsen, G. Pedersen, 2015, The Journal of infectious diseases.

Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV

S. Bojesen, B. Nordestgaard, C. Larsen, 2014, AIDS.

A case of Epstein-Barr virus infection complicated with Guillain-Barré syndrome involving several cranial nerves

C. Pedersen, L. Højberg, Eva Søndergård, 2005, Scandinavian journal of infectious diseases.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.

H. Sørensen, G. Pedersen, G. Kronborg, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients.

H. Sørensen, S. Jensen-Fangel, C. Larsen, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.

A. Mocroft, C. Katlama, A. Phillips, 1997, International journal of epidemiology.

Postmortem Detection of Hepatitis B, C, and Human Immunodeficiency Virus Genomes in Blood Samples from Drug‐Related Deaths in Denmark *

J. L. Thomsen, C. Pedersen, J. Banner, 2009, Journal of forensic sciences.

Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients

C. Larsen, G. Kronborg, C. Pedersen, 2014, AIDS.

Human immunodeficiency virus‐associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein‐Barr virus and human herpesvirus‐8

O. Kirk, S. Hamilton-Dutoit, I. Lisse, 2000, European journal of haematology.

Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.

H. Ullum, C. Larsen, G. Pedersen, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

G. Norkrans, M. Färkkilä, A. Martner, 2014 .

Prevalence of HIV infection in seronegative high-risk individuals examined by virus isolation and PCR.

J. Lundgren, C. Pedersen, C. Nielsen, 1991, Journal of acquired immune deficiency syndromes.

Survival of European patients with Kaposi's sarcoma as AIDS‐defining condition during the first decade of AIDS

C. Katlama, F. Goebel, J. Lundgren, 1997, AIDS.

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression

A. Mocroft, R. Paredes, H. Stellbrink, 2016, Medicine.

High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection.

J. Nielsen, C. Pedersen, K. Krogsgaard, 1991, Journal of acquired immune deficiency syndromes.

K65R with and without S68: A New Resistance Profile in Vivo Detected in Most Patients Failing Abacavir, Didanosine and Stavudine

O. Kirk, J. Lundgren, C. Pedersen, 2003, Antiviral therapy.

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy (vol 162, pg 865, 2000)

A. Mocroft, R. Brettle, O. Kirk, 2003 .

Mortality in siblings of patients coinfected with HIV and hepatitis C virus.

H. Sørensen, G. Kronborg, C. Pedersen, 2007, The Journal of infectious diseases.

Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals

H. Sørensen, C. Larsen, G. Kronborg, 2005, AIDS.

Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.

H. Sørensen, C. Larsen, G. Pedersen, 2006, Clinical Infectious Diseases.

Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study

C. Larsen, G. Pedersen, G. Kronborg, 2016, Journal of acquired immune deficiency syndromes.

Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents

C. Larsen, G. Pedersen, G. Kronborg, 2013, AIDS.

Follicular bronchiolitis in an HIV-infected individual on combination antiretroviral therapy with low CD4+ cell count but sustained viral suppression

C. Laursen, C. Pedersen, L. D. Rasmussen, 2017, BMJ Case Reports.

Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study.

M. May, C. Larsen, G. Kronborg, 2015, The lancet. HIV.

CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV.

C. Larsen, G. Pedersen, G. Kronborg, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Household Transmission of Invasive Group A Streptococcus with Necrotizing Fasciitis

C. Pedersen, U. S. Justesen, Henrik K Laustrup, 2003, Scandinavian journal of infectious diseases.

Clinical Progression of HIV Infection: Role of NK Cells

B. Pedersen, C. Pedersen, H. Bruunsgaard, 1997, Scandinavian journal of immunology.

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

C. Leen, A. Mocroft, R. Weber, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

H. Ullum, S. Nielsen, I. Mathiesen, 2017, BMC Infectious Diseases.

The prognostic value of the suPARnostic® ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms

R. L. Nielsen, C. Pedersen, J. Eugen-Olsen, 2007, BMC infectious diseases.

Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.

C. Pedersen, N. Obel, L. Nielsen, 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex

C. Farthing, D. Cooper, N. Clumeck, 1991 .

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS‐related complex: a double‐blind, randomized trial

M. Moroni, É. Oksenhendler, B. Hirschel, 1993 .

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.

C. Larsen, G. Pedersen, G. Kronborg, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.

C. Katlama, A. Phillips, B. Ledergerber, 1995, Archives of internal medicine.

HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.

A. Iversen, A. Svejgaard, B. Hofmann, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey.

H. Sørensen, C. Pedersen, N. Obel, 2005, AIDS patient care and STDs.

How Well Do Discharge Diagnoses Identify Hospitalised Patients with Community-Acquired Infections? – A Validation Study

J. Hallas, C. Laursen, A. Lassen, 2014, PloS one.

S. Hamilton-Dutoit, C. Pedersen, M. Franzmann, 1991, The American journal of pathology.

The use of calcium carbonate in nelfinavir‐associated diarrhoea in HIV‐1‐infected patients

S. Jensen-Fangel, C. Pedersen, N. Obel, 2003, HIV medicine.

Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C

S. Lethagen, C. Pedersen, A. Laursen, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus

S. Hess, P. Høilund-Carlsen, F. Rosenvinge, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

V. Backer, C. Pedersen, J. Hertz, 1992, Scandinavian journal of infectious diseases.

A sex comparison of rates of new AIDS‐defining disease and death in 2554 AIDS cases

A. Phillips, J. Lundgren, A. Ranki, 1994, AIDS.

Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group.

A. d’Arminio Monforte, C. Katlama, J. Gatell, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The Insufficient Suppression of Viral Load by Saquinavir Hard Gel Is Reversible: A Retrospective Cohort Study

O. Kirk, A. Blaxhult, S. Jensen-Fangel, 2001, HIV clinical trials.

Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for european patients with acquired immunodeficiency syndrome

B. Clotet, C. Katlama, J. Gatell, 1995 .

Zidovudine treatment of AIDS and ARC in Denmark 1987.

O. Bonnevie, C. Pedersen, C. Nielsen, 1989, Scandinavian journal of infectious diseases.

Tuberculosis incidence and mortality in people living with HIV: A Danish nationwide cohort study.

G. Kronborg, C. Pedersen, N. Obel, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The cardiovascular risk management for people living with HIV in Europe: how well are we doing?

A. Mocroft, O. Kirk, A. Schultze, 2016, AIDS.

Outreach screening of drug users for cirrhosis with transient elastography.

M. Vyberg, P. Junker, C. Pedersen, 2011, Addiction.

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

A. Mocroft, O. Kirk, J. Lundgren, 2014, AIDS.

A Randomized Trial Comparing Initial Haart Regimens of Nelfinavir/Nevirapine and Ritonavir/Saquinavir in Combination with Two Nucleoside Reverse Transcriptase Inhibitors

O. Kirk, J. Lundgren, C. Pedersen, 2002, Antiviral therapy.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Lipid‐based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients

M. Christiansen, C. Hagen, A. Aseffa, 2015, HIV medicine.

HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIBODY TESTING IN 862 PATIENTS WITH LYMPHOMA AND LEUKAEMIA ATTENDING A DEPARTMENT OF HAEMATOLOGY (1984–1988)

N. Nissen, C. Pedersen, P. Skinhøj, 1989, European journal of haematology.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine

O. Kirk, J. Lundgren, C. Pedersen, 2003, AIDS.

Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection

J. Lundgren, C. Nielsen, C. Pedersen, 1993, AIDS.

A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study

A. Mocroft, O. Kirk, B. Ledergerber, 2011, HIV clinical trials.

Complete Histological Regression of Kaposi's Sarcoma Following Treatment with Protease Inhibitors Despite Persistence of HHV-8 in Lesions

O. Kirk, T. Benfield, C. Pedersen, 1998 .

The Danish PEP Registry: Experience With the Use of Postexposure Prophylaxis (PEP) Following Sexual Exposure to HIV From 1998 to 2006

G. Kronborg, C. Pedersen, T. Katzenstein, 2010, Sexually transmitted diseases.

Comorbidity Acquired Before HIV Diagnosis and Mortality in Persons Infected and Uninfected With HIV: A Danish Population-Based Cohort Study

H. Sørensen, C. Larsen, G. Pedersen, 2011, Journal of acquired immune deficiency syndromes.

Risk Factors for Hospitalization Due to Community-Acquired Sepsis – A Population-Based Case-Control Study

J. Hallas, A. Pottegård, C. Laursen, 2015, PloS one.

Incidence Rate of Community-Acquired Sepsis Among Hospitalized Acute Medical Patients—A Population-Based Survey*

J. Hallas, C. Laursen, A. Lassen, 2015, Critical care medicine.

Candida esophagitis associated with acute human immunodeficiency virus infection.

C. Pedersen, J. Gerstoft, J. Sindrup, 1987, The Journal of infectious diseases.

The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies.

D R Burton, H J Ditzel, D. Burton, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Cryptococcosis in Denmark: an analysis of 28 cases in 1988-1993.

C. Pedersen, J. Knudsen, H. Kjersem, 1997, Scandinavian journal of infectious diseases.

Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group.

A. Phillips, A. Lazzarin, F. Goebel, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The influence of HTLV‐III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

J. Nielsen, J. Aldershvile, C. Pedersen, 1987, Hepatology.

Clinical course of primary HIV infection: consequences for subsequent course of infection.

E. Scheibel, C. Pedersen, B. L. Jensen, 1989, BMJ.

Skin and oral mucosal changes in patients infected with human immunodeficiency virus.

K. Weismann, C. Pedersen, L. Mathiesen, 1988, Acta dermato-venereologica.

Risk of skin cancer in patients with HIV: A Danish nationwide cohort study

C. Larsen, G. Pedersen, R. Gniadecki, 2018, Journal of the American Academy of Dermatology.

The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.

C. Pedersen, L. Mathiesen, V. Faber, 1987, AIDS.

Regional differences in presentation of AIDS in Europe

A. Mocroft, O. Kirk, A. Blaxhult, 2000, Epidemiology and Infection.

Focus of infection and microbiological etiology in community-acquired infections in hospitalized adult patients in the Faroe Islands

C. Pedersen, S. Gaini, M. Gottfredsson, 2019, BMC Infectious Diseases.

Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

Henrik Nielsen, O. Kirk, J. Lundgren, 1999, AIDS.

Severe Actinomyces israelii infection involving the entire spinal cord

C. Pedersen, S. Gaïni, A. Brenøe, 2006, Scandinavian journal of infectious diseases.

T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverters.

J. Lundgren, C. Pedersen, L. Ryder, 1990, AIDS.

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.

C. Farthing, D. Cooper, N. Clumeck, 1991, AIDS (London).

Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study.

J. Nielsen, C. Pedersen, L. Mathiesen, 1989, AIDS.

Randomized comparison of 12 or 24 weeks of peginterferon α‐2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2008, Hepatology.

Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.

N. Klitgaard, K. Brøsen, C. Pedersen, 2003, British journal of clinical pharmacology.

Molecular epidemiology of hepatitis B virus infections in Denmark.

C. Pedersen, J. Georgsen, P. Christensen, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Decreasing Rate of Multiple Treatment Modifications among Individuals who Initiated Antiretroviral Therapy in 1997–2009 in the Danish HIV Cohort Study

C. Larsen, G. Pedersen, G. Kronborg, 2013, Antiviral therapy.

Amprenavir is an effective inducer of delavirdine metabolism - A Steady-State Pharmacokinetic Interaction Study Between Amprenavir and Delavirdine in Healthy Volunteers

N. Klitgaard, K. Brøsen, C. Pedersen, 2000 .

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.

Z. Fox, P. Vernazza, M. Youle, 2003, The Journal of infectious diseases.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Hepatitis C treatment response kinetics and impact of baseline predictors

G. Norkrans, M. Färkkilä, K. Hellstrand, 2011, Journal of viral hepatitis.

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

G. Norkrans, M. Färkkilä, N. Langeland, 2011, Journal of viral hepatitis.

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.

M. Moroni, É. Oksenhendler, B. Hirschel, 1993, AIDS.

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3

G. Norkrans, M. Färkkilä, K. Hellstrand, 2012, PloS one.

Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients.

N. Klitgaard, K. Brøsen, C. Pedersen, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Handan Wand, Sean Emery, Daniel E Nixon, 2011, The Journal of infectious diseases.

Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population

H. Sørensen, S. Jensen-Fangel, C. Larsen, 2003, AIDS.

[Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].

C. Pedersen, U. S. Justesen, 2000, Ugeskrift for laeger.

Dose-dependent pharmacokinetics of delavirdine in combination with amprenavir in healthy volunteers.

N. Klitgaard, K. Brøsen, C. Pedersen, 2004, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.

Z. Fox, J. Lundgren, P. Cahn, 2007, Basic & clinical pharmacology & toxicology.

Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome

J. Lundgren, C. Nielsen, C. Pedersen, 1996, AIDS.

Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data

J. Kaldor, M. Law, M. Clements, 2003, HIV medicine.

Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE*

V. Beral, J. Kaldor, N. Day, 2000, AIDS.

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

O. Kirk, F. Antunes, C. Katlama, 2001, Blood.

IDENTIFICATION OF EBV-DNA IN TUMOUR CELLS OF AIDS-RELATED LYMPHOMAS BY IN-SITU HYBRIDISATION

S. Hamilton-Dutoit, C. Pedersen, G. Pallesen, 1989, The Lancet.

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls.

G. Dubin, S. Silfverdal, D. Descamps, 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women

M. Lehtinen, D. Descamps, C. Pedersen, 2011, International journal of cancer.

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine

M. Einstein, M. Levin, G. Dubin, 2010, Human vaccines.

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.

M. Lehtinen, J. Richardus, B. Spiessens, 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

A. Svejgaard, B. Hofmann, P. Garred, 1997, The Lancet.

Tubuloreticular inclusions in skin biopsies from patients with HIV infection

J. Nielsen, T. Horn, C. Pedersen, 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Incidence and mortality of hypotension in the emergency department; an 12-year population based study

A. Lassen, D. Henriksen, C. Pedersen, 2015, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

Regional survival differences across Europe in HIV-positive people: the EuroSIDA study.

A. Mocroft, J. Lundgren, C. Katlama, 1999, AIDS.

Gastroenteritis and the novel picornaviruses aichi virus, cosavirus, saffold virus, and salivirus in young children.

B. Böttiger, C. Pedersen, L. P. Nielsen, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Low Completeness of Bacteraemia Registration in the Danish National Patient Registry

K. Gradel, H. J. Kolmos, H. Schønheyder, 2015, PloS one.

Characteristics of patients with community-acquired bacteremia who have low levels of C-reactive protein (≤20 mg/L).

K. Gradel, H. J. Kolmos, A. Lassen, 2014, The Journal of infection.

Autologous HIV‐1 Neutralizing Antibodies: Emergence of Neutralization‐Resistant Escape Virus and Subsequent Development of Escape Virus Neutralizing Antibodies

J. Hansen, J. Nielsen, M. Arendrup, 1992, Journal of acquired immune deficiency syndromes.

Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study.

C. Nielsen, C. Pedersen, L. Mathiesen, 2011, AIDS research and human retroviruses.

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

A. Aseffa, M. Tesfaye, H. Friis, 2014, BMC Infectious Diseases.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

HIV neutralizing antibodies: development and association with HIV related disease.

J. Nielsen, M. Arendrup, C. Pedersen, 1989, Scandinavian journal of infectious diseases.

The development of AIDS or AIDS‐related conditions in a cohort of HIV antibody‐positive homosexual men during a 3‐year follow‐up period

C. Pedersen, S. Ullman, J. Gerstoft, 1989, Journal of internal medicine.

Anal carcinoma in HIV-infected patients in the period 1995–2009: A Danish nationwide cohort study

C. Larsen, G. Pedersen, G. Kronborg, 2013, Scandinavian journal of infectious diseases.

Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials

R. Davey, J. Gatell, D. Duprez, 2008, HIV clinical trials.

Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study Group.

A. Phillips, A. Lazzarin, J. Lundgren, 1996, Journal of clinical epidemiology.

Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality – a cohort study

C. Pedersen, J. Johansen, D. B. Holmgaard, 2015, Journal of Inflammation.

Lung cancer in HIV patients and their parents: A Danish cohort study

Gitte Pedersen, C. Larsen, G. Pedersen, 2011, BMC Cancer.

Head and neck cancer in HIV patients and their parents: a Danish cohort study

Gitte Pedersen, C. Larsen, G. Pedersen, 2011, Clinical epidemiology.

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C

P. Bech, G. Norkrans, M. Färkkilä, 2010, Hepatology.

Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking.

B. Nordestgaard, M. May, C. Larsen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study

H. Christensen, G. Kronborg, C. Pedersen, 2011, AIDS.

Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.

B. Nordestgaard, C. Larsen, G. Pedersen, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development

K. Bendix, S. Hamilton-Dutoit, B. Honoré, 2016, AIDS.

Isolation of HIV from cultures of purified CD4+ lymphocytes.

P. Gøtzsche, M. Arendrup, C. Pedersen, 1991, Journal of virological methods.

Serological markers of primary HIV infection.

E. Scheibel, C. Pedersen, B. Lindhardt, 1989, Scandinavian journal of infectious diseases.

A comparison of three methods for detection of antibodies against the major core protein p24 of human immunodeficiency virus.

C. Pedersen, P. Kusk, B. Lindhardt, 1988, Journal of virological methods.

Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus.

Staffan Nilsson, Johan Westin, Gunnar Norkrans, 2011, The Journal of infectious diseases.

Risk factors for contagious gastroenteritis in adult patients with diarrhoea in the emergency department - a prospective observational multicentre study

V. Andersen, C. Pedersen, Ming Chen, 2019, BMC Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study.

C. Pedersen, S. Ostrowski, P. Johansson, 2015, Journal of critical care.

Efficacy and safety of two different dose levels of ganciclovir for the treatment of cytomegalovirus chorioretinitis in AIDS patients.

J. Nielsen, C. Pedersen, V. Faber, 1988, Scandinavian journal of infectious diseases.

Full-length characterization of A1/D intersubtype recombinant genomes from a therapy-induced HIV type 1 controller during acute infection and his noncontrolling partner.

L. Vinner, A. Fomsgaard, C. Nielsen, 2008, AIDS research and human retroviruses.

Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study

C. Pedersen, P. Christensen, B. Mössner, 2014, PloS one.

Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study

C. Pedersen, S. Gaïni, S. Pedersen, 2006, Critical care.

Incidence and prevalence of hospital-acquired infections in a cohort of patients admitted to medical departments.

A. Lassen, C. Pedersen, S. Pedersen, 2010, Danish medical bulletin.

Effect of the Serotonin Receptor Agonist, Buspirone, on Immune Function in HIV-Infected Individuals: A Six-Month Randomized, Double-Blind, Placebo-Controlled Trial

J. Parner, J. Iversen, T. Benfield, 2000, HIV clinical trials.

Employment status in persons with and without HIV infection in Denmark: 1996–2011

C. Larsen, G. Pedersen, G. Kronborg, 2014, AIDS.

Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study

C. Larsen, G. Pedersen, G. Kronborg, 2012, AIDS.

Widespread use of condoms and low prevalence of sexually transmitted diseases in Danish non-drug addict prostitutes.

J. Nielsen, C. Gluud, C. Pedersen, 1986, British medical journal.

Infectious gastroenteritis and the need for strict contact precaution procedures in adults presenting to the emergency department: a Danish register-based study.

V. Andersen, C. Pedersen, Ming Chen, 2017, The Journal of hospital infection.

Intermediate-term and long-term mortality among acute medical patients hospitalized with community-acquired sepsis: a population-based study

J. Hallas, A. Pottegård, C. Laursen, 2017, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Reduced ability to work both before and after infectious spondylodiscitis in working-age patients

J. Hallas, A. Lassen, C. Pedersen, 2017, Infectious diseases.

University of Southern Denmark Association between hypoalbuminaemia and mortality in patients with community-acquired bacteraemia is primarily related to acute disorders

H. J. Kolmos, C. Pedersen, B. Magnussen, 2016 .

Mortality and prognostic factors of patients who have blood cultures performed in the emergency department: a cohort study

H. J. Kolmos, A. Lassen, D. Henriksen, 2016, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Time to initial antibiotic administration, and short-term mortality among patients admitted with community-acquired severe infections with and without the presence of systemic inflammatory response syndrome: a follow-up study

J. Hallas, C. Laursen, A. Lassen, 2015, Emergency Medicine Journal.

Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study.

J. Hallas, K. Gradel, H. J. Kolmos, 2015, The Journal of infection.

No Specific Time Window Distinguishes between Community-, Healthcare-, and Hospital-Acquired Bacteremia, but They Are Prognostically Robust

K. Gradel, H. J. Kolmos, H. Schønheyder, 2014, Infection Control & Hospital Epidemiology.

How do bacteraemic patients present to the emergency department and what is the diagnostic validity of the clinical parameters; temperature, C-reactive protein and systemic inflammatory response syndrome?

H. J. Kolmos, A. Lassen, D. Henriksen, 2014, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

Does C‐reactive protein independently predict mortality in adult community‐acquired bacteremia patients with known sepsis severity?

K. Gradel, A. Lassen, C. Pedersen, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

C. Larsen, G. Kronborg, C. Pedersen, 2013, PloS one.

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

G. Norkrans, M. Färkkilä, K. Hellstrand, 2012, PloS one.

Use of the Protease Inhibitor Saquinavir Hard Gel in Human Immunodeficiency Virus-infected Patients in the Early Period of Highly Active Antiretroviral Therapy: Does it Affect Long-term Treatment Outcome?

H. Sørensen, S. Jensen-Fangel, C. Pedersen, 2003, Scandinavian journal of infectious diseases.

Characterization of HIV‐1 from patients with virological failure to a boosted protease inhibitor regimen

G. Kronborg, C. Pedersen, N. Obel, 2011, Journal of medical virology.

High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study

H. Møller, C. Pedersen, S. Gaïni, 2007, Critical care.

Reporting and Evaluation of HIV-Related Clinical Endpoints in Two Multicenter International Clinical Trials

R. Davey, J. Gatell, W. El-Sadr, 2006, HIV clinical trials.

New immunological serum markers in bacteraemia: anti‐inflammatory soluble CD163, but not proinflammatory high mobility group‐box 1 protein, is related to prognosis

S. Moestrup, H. Møller, C. Pedersen, 2008, Clinical and experimental immunology.

Complete histological regression of Kaposi's sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions.

O. Kirk, T. Benfield, C. Pedersen, 1998, Scandinavian journal of infectious diseases.

Epidemiology of community-acquired sepsis in the Faroe Islands – a prospective observational study

C. Pedersen, S. Gaini, M. Gottfredsson, 2018, Infectious diseases.

Prediction of 28-days mortality with sequential organ failure assessment (SOFA), quick SOFA (qSOFA) and systemic inflammatory response syndrome (SIRS) - A retrospective study of medical patients with acute infectious disease.

C. Pedersen, I. Johansen, S. Gaini, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis

H. Møller, C. Pedersen, I. Johansen, 2018, Scandinavian journal of clinical and laboratory investigation.

after endotoxin challenge in humans Gene expression profiles of peripheral blood leukocytes

P. Munson, S. Lewin, J. Brenchley, 2011 .

Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study

H. Sørensen, C. Larsen, G. Pedersen, 2011, PloS one.

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

J. Søndergaard, C. Pedersen, N. Obel, 2019, HIV medicine.

Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.

C. Pedersen, N. Obel, L. Nielsen, 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.

G. Kronborg, C. Pedersen, N. Obel, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

A. Mocroft, R. Brettle, O. Kirk, 2000, American journal of respiratory and critical care medicine.

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine

Anne M Johnson, Andrew N. Phillips, Reggio Emilia, 1994 .

Tuberculosis in homosexual men with HIV disease.

J. Nielsen, C. Pedersen, 1987, Scandinavian Journal of Infectious Diseases.

Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.

C. Katlama, J. Lundgren, N. Clumeck, 1996, AIDS.

Good performance of an immunoassay based method for nevirapine measurements in human breast milk

C. Pedersen, J. Gerstoft, M. Chiduo, 2011, Clinical chemistry and laboratory medicine.

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.

J. Nielsen, J. Gatell, A. Phillips, 1994, JAMA.

Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.

A. Blaxhult, B. Clotet, C. Katlama, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group.

J. Nielsen, C. Katlama, J. Gatell, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study

C. Larsen, G. Pedersen, G. Kronborg, 2012, AIDS.

Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003

D. Pillay, G. Poggensee, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community‐acquired infections

S. Moestrup, C. Pedersen, S. Gaïni, 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Genotypic and Phenotypic Nevirapine Resistance Correlates with Virological Failure during Salvage Therapy Including Abacavir and Nevirapine

C. Nielsen, C. Pedersen, L. Mathiesen, 1999, Antiviral therapy.

Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.

O. Kirk, A. Blaxhult, J. Lundgren, 1999, Scandinavian journal of infectious diseases.

C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection.

P. Póvoa, K. Gradel, H. J. Kolmos, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Plasma cytokines eotaxin, MIP‐1α, MCP‐4, and vascular endothelial growth factor in acute lower respiratory tract infection

C. Pedersen, A. Holm, M. M. Relster, 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study

S. Jensen-Fangel, C. Larsen, G. Kronborg, 2005, Scandinavian journal of infectious diseases.

Polymorphism in interleukin-7 receptor &agr; gene is associated with faster CD4+ T-cell recovery after initiation of combination antiretroviral therapy

H. Ullum, S. Nielsen, C. Larsen, 2014, AIDS.

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3

G. Norkrans, M. Färkkilä, A. Martner, 2014, Hepatology.

Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.

C. Pedersen, L. Teglbjaerg, S. Ingeberg, 1989, AIDS.

SERUM THYMIDINE KINASE IN AIDS PATIENTS TREATED WITH ZIDOVUDINE

C. Pedersen, S. Ingeberg, 1987, The Lancet.

HIV-Specific ADCC Improves After Antiretroviral Therapy and Correlates With Normalization of the NK Cell Phenotype

A. Fomsgaard, S. Nielsen, C. Pedersen, 2015, Journal of acquired immune deficiency syndromes.

Cause-Specific Excess Mortality in Siblings of Patients Co-Infected with HIV and Hepatitis C Virus

H. Sørensen, G. Kronborg, C. Pedersen, 2007, PloS one.

Isolation of HIV using T-lymphocyte 'panning': methodological aspects.

C. Pedersen, C. Nielsen, L. Mathiesen, 1989, Journal of virological methods.

Six billion neurons lost in AIDS

H. Gundersen, J. Nielsen, C. Pedersen, 1995 .

Six billion neurons lost in AIDS. A stereological study of the neocortex.

B. Pakkenberg, H. Gundersen, J. Nielsen, 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Cerebral atrophy in AIDS: a stereological study

B. Pakkenberg, H. J. G. Gundersen, B. Pakkenberg, 2004, Acta Neuropathologica.

Analysis of Virological Efficacy in Trials of Antiretroviral Regimens: Drawbacks of Not Including Viral Load Measurements after Premature Discontinuation of Therapy

O. Kirk, J. Montaner, A. Phillips, 2001, Antiviral therapy.

Rapid development of AIDS in an HIV-1-antibody-negative homosexual man.

C. Nielsen, C. Pedersen, P. Skinhøj, 1995, AIDS (London).

Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection

D. Cooper, J. Weber, M. Schechter, 2012, PloS one.

Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells

A. Fomsgaard, G. Kronborg, C. Pedersen, 2015, PloS one.

Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.

F. Goebel, A. Johnson, C. Pedersen, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A preliminary report on the neuropsychologic sequelae of human immunodeficiency virus.

J. Parnas, S. Lunn, C. Pedersen, 1991, Archives of general psychiatry.

Ranitidine improves certain cellular immune responses in asymptomatic HIV-infected individuals.

J. Nielsen, H. Kehlet, C. Pedersen, 1991, Journal of acquired immune deficiency syndromes.

Development of resistance to zidovudine (ZDV) and didanosine (ddl) in HIV from patients in ZDV, ddl and alternating ZDV/ddl therapy

C. Nielsen, C. Pedersen, L. Mathiesen, 1996, AIDS.

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C

J. Bukh, P. Madsen, H. Krarup, 2012, Scandinavian journal of gastroenterology.

Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?

G. Norkrans, M. Färkkilä, K. Hellstrand, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of IL 28 B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3

G. Norkrans, M. Färkkilä, N. Langeland, 2022 .

The value of lymph node histology in human immunodeficiency virus related persistent generalized lymphadenopathy.

C. Pedersen, L. Mathiesen, J. Gerstoft, 1989, APMIS. Supplementum.

The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS‐related complex

Ruedi Lüthy, Peter Skinhøj, David A. Cooper, 1992, AIDS.

Isolation of HIV-1 from small volumes of heparinized whole blood.

C. Pedersen, R. Jordal, Nielsen Jo, 1989 .

Diurnal variation of plasma protease inhibitor concentrations.

C. Pedersen, U. S. Justesen, 2002, AIDS.

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)

A. Fomsgaard, G. Kronborg, C. Pedersen, 2015, PloS one.

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression

A. Mocroft, R. Paredes, C. Pedersen, 2014, Journal of the International AIDS Society.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.

Long-term Effectiveness of Recommanded Boosted PI-Based Antiretroviral Therapy in Europe

A. Blaxhult, R. Paredes, A. Phillips, 2014 .

No effect of isoprinosine on HIV infection in vitro.

C. Pedersen, L. Mathiesen, J. Hansen, 1990, AIDS.

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

G. Norkrans, M. Färkkilä, N. Langeland, 2015, Scandinavian journal of gastroenterology.

A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study

H. Møller, C. Pedersen, S. Gaïni, 2007, Critical care.

Bacteremia with Anaerobic Bacteria and Association with Colorectal Cancer: A Population-based Cohort Study.

R. Dessau, K. Gradel, C. Pedersen, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver stiffness and 30‐day mortality in a cohort of patients admitted to hospital

S. Lillevang, C. Pedersen, P. Christensen, 2012, European journal of clinical investigation.

HIV-Specific CD8+ T Cell–Mediated Viral Suppression Correlates With the Expression of CD57

A. Fomsgaard, G. Kronborg, C. Pedersen, 2016, Journal of acquired immune deficiency syndromes.

A Novel Fibrosis Index Comprising a Non-Cholesterol Sterol Accurately Predicts HCV-Related Liver Cirrhosis

G. Norkrans, M. Färkkilä, N. Langeland, 2014, PloS one.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015

B. Gazzard, A. Mocroft, A. d’Arminio Monforte, 2019, PloS one.

The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999–2012

M. Storgaard, G. Kronborg, C. Pedersen, 2016, Infectious diseases.

[Post-exposure prophylaxis after sexual or occupational exposure to HIV].

C. Pedersen, N. Obel, U. Balslev, 2003, Ugeskrift for læger.

Declining Prevalence of HIV-Infected Individuals at Risk of Transmitting Drug-Resistant HIV in Denmark during 1997–2004

H. Sørensen, C. Larsen, G. Kronborg, 2005, Antiviral therapy.

Prevalence of Drug Resistance Mutations and Non-B Subtypes in Newly Diagnosed HIV-1 Patients in Denmark

C. Nielsen, C. Pedersen, N. Obel, 2003, Scandinavian journal of infectious diseases.

Mortality after Hospitalization for Pneumonia among Individuals with HIV, 1995–2008: A Danish Cohort Study

H. Sørensen, G. Pedersen, G. Kronborg, 2009, PloS one.

Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors

C. Pedersen, N. Weis, S. Hallager, 2017, Open forum infectious diseases.

Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2011, Hepatology.

PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2012, BMC Medical Genetics.

C-reactive protein and albumin kinetics before community-acquired bloodstream infections – a Danish population-based cohort study

P. Póvoa, K. Gradel, H. J. Kolmos, 2020, Epidemiology and Infection.

University of Southern Denmark C-reactive protein and albumin kinetics before community-acquired bloodstream infections- A Danish population-based cohort study

P. Póvoa, K. Gradel, H. J. Kolmos, 2020 .

Nontraumatic Hypotension and Shock in the Emergency Department and the Prehospital setting, Prevalence, Etiology, and Mortality: A Systematic Review

Annmarie Touborg Lassen, A. Lassen, D. Henriksen, 2014, PloS one.

Associations between HIV-RNA-based indicators and virological and clinical outcomes

A. Mocroft, O. Kirk, J. Lundgren, 2016, AIDS.

Travelling with HIV: a cross sectional analysis of Danish HIV-infected patients.

S. Jensen-Fangel, C. Larsen, G. Pedersen, 2014, Travel medicine and infectious disease.

Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography.

N. Klitgaard, C. Pedersen, U. S. Justesen, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Weight‐adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short‐term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2008, Hepatology.

Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark.

C. Pedersen, P. Søgaard, S. Skarphédinsson, 2001, Scandinavian journal of infectious diseases.

The long‐term pharmacokinetics and safety of adding low‐dose ritonavir to a nelfinavir 1250 mg twice‐daily regimen in HIV‐infected patients

C. Pedersen, J. Gerstoft, F. Black, 2005, HIV medicine.

Increasing incidence of hypotension in the emergency department; a 12 year population-based cohort study

A. Lassen, D. Henriksen, C. Pedersen, 2016, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

Reactivation of viral replication in anti-HBe positive chronic HBsAg carriers.

J. Nielsen, H. Dalbøge, B. Hansson, 2008, Liver.

Surveillance of HIV and Viral Hepatitis by Analysis of Samples from Drug Related Deaths

J. L. Thomsen, C. Pedersen, J. Banner, 2006, European Journal of Epidemiology.

The LAV/HTLV-III screening in Copenhagen. Epidemiological results from four clinics over the period 1 July 1984 to 1 April 1985.

M. Arendrup, C. Pedersen, J. Gerstoft, 1986, Danish medical bulletin.

Hypoalbuminaemia as a marker of trans-capillary leakage in community-acquired bacteraemia patients

K. Gradel, H. J. Kolmos, A. Lassen, 2018, Epidemiology and Infection.

Opportunistic infections and malignancies in 231 Danish AIDS patients

P. Gøtzsche, J. Lundgren, C. Pedersen, 1990, AIDS.

Syddansk Universitet Increasing incidence of hypotension in the emergency department a 12 year population-based cohort study

A. Lassen, D. Henriksen, C. Pedersen, 2016 .

HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features.

S. Hamilton-Dutoit, J. Lundgren, C. Geisler, 1991, European journal of cancer.

Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV‐infected individuals from 1995 to 2007: a nationwide cohort study *

C. Larsen, R. Skov, G. Kronborg, 2011, HIV medicine.

Syddansk Universitet Shock in the emergency department a 12 year population based cohort study

A. Lassen, D. Henriksen, C. Pedersen, 2016 .

Biological phenotype of HIV-1 and transmission.

J. Lundgren, J. Albert, E. Fenyö, 1995, AIDS.

Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.

M. Arendrup, C. Pedersen, J. Gerstoft, 1986, Danish medical bulletin.

High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study

H. Møller, C. Pedersen, S. Gaïni, 2007, Critical care.

The effectiveness of indicator disease-based HIV testing across Europe - results from a prospective multi-centre study

M. Jakobsen, B. Gazzard, A. Mocroft, 2015 .

HIV and risk of venous thromboembolism: a Danish nationwide population‐based cohort study

C. Larsen, G. Pedersen, G. Kronborg, 2011, HIV medicine.

Toxoplasmosis in Danish AIDS patients.

J. Lundgren, C. Pedersen, J. Gerstoft, 1997, Scandinavian Journal of Infectious Diseases.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

G. Norkrans, M. Färkkilä, K. Hellstrand, 2011, Hepatology.

Reply: To PMID 24519039.

G. Norkrans, M. Färkkilä, A. Martner, 2014, Hepatology.

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

D. Podzamczer, C. Katlama, H. Furrer, 2012, The Journal of antimicrobial chemotherapy.

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

A. Mocroft, O. Kirk, J. Lundgren, 2010, AIDS.

HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.

K. D. Jakobsen, B. Hofmann, N. Odum, 1989, Journal of immunology.

Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders

H. J. Kolmos, C. Pedersen, B. Magnussen, 2016, PloS one.

Real-life data patterns of C-reactive protein and albumin level trajectories around bacteremia.

P. Póvoa, K. Gradel, H. J. Kolmos, 2018, Biomarkers in medicine.

The daily risk of bacteremia during hospitalization and associated 30-day mortality evaluated in relation to the traditional classification of bacteremia.

K. Gradel, H. J. Kolmos, A. Lassen, 2016, American journal of infection control.

Mortality and prognostic factors of patients who have blood cultures performed in the emergency department: a cohort study

H. J. Kolmos, A. Lassen, D. Henriksen, 2016, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

S. Lewin, D. Douek, J. Brenchley, 2011, The Journal of infectious diseases.

New immunological serum markers in bacteraemia: anti‐inflammatory soluble CD163, but not proinflammatory high mobility group‐box 1 protein, is related to prognosis

S. Moestrup, H. Møller, C. Pedersen, 2008, Clinical and experimental immunology.

Central nervous system involvement in human immunodeficiency virus disease. A prospective study including neurological examination, computerized tomography, and magnetic resonance imaging.

P. Arlien‐Søborg, C. Thomsen, C. Pedersen, 1991, Danish medical bulletin.

No change in viral set point or CD4 cell decline among antiretroviral treatment‐naïve, HIV‐1‐infected individuals enrolled in the Danish HIV Cohort Study in 1995–2010

G. Pedersen, G. Kronborg, C. Pedersen, 2013, HIV medicine.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study #_#x2013; 2012 #_#x2013; 2015

A. Mocroft, J. Gatell, J. Lundgren, 2019 .

Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C

S. Lethagen, C. Pedersen, A. Laursen, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Renal function and incidence of chronic kidney disease in HIV patients: A Danish cohort study

O. Kirk, B. Feldt-Rasmussen, G. Kronborg, 2012, Scandinavian journal of infectious diseases.

Risk of skin cancer in HIV-infected patients: a Danish nationwide cohort study

Birgit, C. Larsen, G. Pedersen, 2018 .

Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study.

M. May, C. Larsen, G. Kronborg, 2015, The lancet. HIV.

Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials

R. Davey, J. Gatell, D. Duprez, 2010, HIV clinical trials.

Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.

C. Pedersen, N. Obel, L. Nielsen, 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

S. Hamilton-Dutoit, F. d'Amore, M. Møller, 2022, Leukemia & lymphoma.